Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Targeted Oncology|October 14, 2022
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal CancerGianluca Arrichiello, Alessandra Perrone, Stefania Napolitano, et al.
International Journal of Cancer|May 1, 2013
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cellsErika Martinelli, Teresa Troiani, Elena D'Aiuto, et al.
Frontiers in Oncology|August 5, 2022
Beyond N staging in colorectal cancer: Current approaches and future perspectivesGianluca Arrichiello, Mario Pirozzi, Bianca Arianna Facchini, et al.
Oncotarget|May 13, 2015
AXL is an oncotarget in human colorectal cancerErika Martinelli, Giulia Martini, Claudia Cardone, et al.
International Journal of Cancer|April 16, 2022
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumabGiulia Martini, Davide Ciardiello, Marcello Dallio, et al.
Clinical Drug Investigation|June 17, 2024
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 TrialErika Martinelli, Davide Ciardiello, Giulia Martini, et al.
ESMO Open|December 7, 2017
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatmentErika Martinelli, Vincenzo Sforza, Claudia Cardone, et al.
Nature Communications|March 16, 2025
Early warning of complex climate risk with integrated artificial intelligenceMarkus Reichstein, Vitus Benson, Jan Blunk, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 7, 2021
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancerPietro Paolo Vitiello, Giulia Martini, Luigi Mele, et al.
The Lancet. Child & Adolescent Health|June 19, 2024
Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysisMaria Rogdaki, Robert A McCutcheon, Enrico D'Ambrosio, et al.
Pageof 9